Appearance of new strains associated with group B meningococcal disease and their use for rapid vaccine development-Reference-Cited by-同舟云学术

Appearance of new strains associated with group B meningococcal disease and their use for rapid vaccine development

Published:1987-11 Issue:6 Volume:53 Page:395-402
ISSN:0003-6072
Container-title:Antonie van Leeuwenhoek
language:en
Short-container-title:Antonie van Leeuwenhoek

Author:

Frasch C. E.,Mocca L. F.,Karpas A. B.

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,General Medicine,Microbiology

Link

http://link.springer.com/content/pdf/10.1007/BF00415493.pdf

Reference16 articles.

1. Caugant, D. A., L. O. Froholm, K. Bovre, E. Holten, C. E. Frasch, L. F. Mocca, W. D. Zollinger & R. K. Selander (1986) Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc. Natl. Acad. Sci. USA 83: 4927–4931

2. Caugant, D. A., F. L. Mocca, C. E. Frasch, L. O. Froholm, W. D. Zollinger & R. K. Selander (1987) Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J. Bacteriol 169: 2781–2792

3. Craven, D. E., C. E. Frasch, L. F. Mocca, F. B. Rose & R. Gonzalez (1979) Rapid serogroup identification of Neisseria meningiditis by using antiserum agar: prevalence of serotypes in a disease-free military population. J. Clin. Microbiol. 10: 302–307

4. Frasch, C. E. & S. S. Chapman (1973) Classification of Neisseria meningitidis group b into distinct serotypes. III. Application of a new bactericidal inhibition technique to distribution of serotypes among cases and carriers. J. Infect. Dis. 127: 149–154

5. Frasch, C. E., G. Coetzee, J. M. Zahradnik & L. Y. Wang (1985a) New developments in meningococcal vaccines. In: G. K. Schoolnik (Ed) The pathogenic Neisseria (pp. 633–639). ASM, Washington, D. C.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives;Expert Review of Vaccines;2015-01-21

2. A Consensus Statement;Pediatric Infectious Disease Journal;2014-03

3. History of meningococcal vaccines and their serological correlates of protection;Vaccine;2012-05

4. Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age;Vaccine;2000-02

5. Incorporation of bacterial membrane proteins into liposomes: factors influencing protein reconstitution;Biochimica et Biophysica Acta (BBA) - Biomembranes;1999-09